Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review

At present, RNA-based therapy which includes therapies using non-coding RNAs (ncRNAs), antisense oligonucleotides (ASOs), and aptamers are gaining widespread attention as possible ways to target genes in various cardiovascular diseases (CVDs), thereby serving as a promising therapeutic approach for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardiana, Meity, Fadila, Asiyah Nurul, Zuhra, Zakirah, Kusuma, Nabilla Merdika, Surya Erlangga Rurus, Made Edgard, Oceandy, Delvac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362275/
https://www.ncbi.nlm.nih.gov/pubmed/37483458
http://dx.doi.org/10.1016/j.ncrna.2023.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362275/
https://www.ncbi.nlm.nih.gov/pubmed/37483458
http://dx.doi.org/10.1016/j.ncrna.2023.06.002

Ejemplares similares